PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-36.84%
Negative revenue growth while 8198.HK stands at 821.16%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-31.68%
Negative gross profit growth while 8198.HK is at 169.57%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-65.33%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-131.12%
Negative net income growth while 8198.HK stands at 21.89%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-126.95%
Negative EPS growth while 8198.HK is at 19.23%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-126.95%
Negative diluted EPS growth while 8198.HK is at 23.08%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.94%
Negative OCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-87.48%
Negative FCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-92.57%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-95.33%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-86.51%
Negative 3Y CAGR while 8198.HK stands at 728.43%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-145.63%
Negative 10Y OCF/share CAGR while 8198.HK stands at 49.58%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-55.38%
Negative 5Y OCF/share CAGR while 8198.HK is at 13.52%. Joel Greenblatt would question the firm’s operational model or cost structure.
-117.28%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-242.86%
Negative 10Y net income/share CAGR while 8198.HK is at 84.75%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-2756.04%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-603.24%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-1.32%
Negative equity/share CAGR over 10 years while 8198.HK stands at 103.50%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-21.18%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-12.28%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-11.54%
Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
407.97%
Inventory growth of 407.97% while 8198.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-3.75%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.52%
We have a declining book value while 8198.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-31.66%
We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
18.94%
We expand SG&A while 8198.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.